Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
COVID-19
/ complications
COVID-19 Nucleic Acid Testing
Child
Child, Preschool
Cross-Sectional Studies
Female
Humans
Infant
Male
Middle Aged
RNA, Viral
/ metabolism
Reverse Transcriptase Polymerase Chain Reaction
SARS-CoV-2
/ isolation & purification
Symptom Assessment
Viral Load
Washington
Young Adult
Journal
JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
pubmed:
12
6
2021
medline:
16
10
2021
entrez:
11
6
2021
Statut:
ppublish
Résumé
The association between COVID-19 symptoms and SARS-CoV-2 viral levels in children living in the community is not well understood. To characterize symptoms of pediatric COVID-19 in the community and analyze the association between symptoms and SARS-CoV-2 RNA levels, as approximated by cycle threshold (Ct) values, in children and adults. This cross-sectional study used a respiratory virus surveillance platform in persons of all ages to detect community COVID-19 cases from March 23 to November 9, 2020. A population-based convenience sample of children younger than 18 years and adults in King County, Washington, who enrolled online for home self-collection of upper respiratory samples for SARS-CoV-2 testing were included. Detection of SARS-CoV-2 RNA by reverse transcription-polymerase chain reaction (RT-PCR) from participant-collected samples. RT-PCR-confirmed SARS-CoV-2 infection, with Ct values stratified by age and symptoms. Among 555 SARS-CoV-2-positive participants (mean [SD] age, 33.7 [20.1] years; 320 were female [57.7%]), 47 of 123 children (38.2%) were asymptomatic compared with 31 of 432 adults (7.2%). When symptomatic, fewer symptoms were reported in children compared with adults (mean [SD], 1.6 [2.0] vs 4.5 [3.1]). Symptomatic individuals had lower Ct values (which corresponded to higher viral RNA levels) than asymptomatic individuals (adjusted estimate for children, -3.0; 95% CI, -5.5 to -0.6; P = .02; adjusted estimate for adults, -2.9; 95% CI, -5.2 to -0.6; P = .01). The difference in mean Ct values was neither statistically significant between symptomatic children and symptomatic adults (adjusted estimate, -0.7; 95% CI, -2.2 to 0.9; P = .41) nor between asymptomatic children and asymptomatic adults (adjusted estimate, -0.6; 95% CI, -4.0 to 2.8; P = .74). In this community-based cross-sectional study, SARS-CoV-2 RNA levels, as determined by Ct values, were significantly higher in symptomatic individuals than in asymptomatic individuals and no significant age-related differences were found. Further research is needed to understand the role of SARS-CoV-2 RNA levels and viral transmission.
Identifiants
pubmed: 34115094
pii: 2780963
doi: 10.1001/jamapediatrics.2021.2025
pmc: PMC8491103
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e212025Subventions
Organisme : NIGMS NIH HHS
ID : R35 GM119774
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007044
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007233
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
N Engl J Med. 2020 Jul 9;383(2):185-187
pubmed: 32356944
EClinicalMedicine. 2020 Jun 26;24:100433
pubmed: 32766542
Clin Infect Dis. 2021 Jun 15;72(12):2215-2217
pubmed: 32710743
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
JAMA Pediatr. 2020 Sep 1;174(9):902-903
pubmed: 32745201
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Pediatrics. 2020 Aug;146(2):
pubmed: 32457212
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Lancet. 2021 Jan 9;397(10269):93-94
pubmed: 33347812
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452
pubmed: 32780793
J Med Virol. 2021 Feb;93(2):820-830
pubmed: 32691881
Emerg Infect Dis. 2020 Oct;26(10):2494-2497
pubmed: 32603290
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33093026
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404
Pediatr Infect Dis J. 2020 Dec;39(12):e388-e392
pubmed: 33031141
PLoS One. 2021 Apr 14;16(4):e0245423
pubmed: 33852576
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):596-608
pubmed: 32840614
JAMA Netw Open. 2020 Jul 1;3(7):e2016382
pubmed: 32697321
Lancet Infect Dis. 2021 May;21(5):617-628
pubmed: 33476567
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Sci Rep. 2021 Feb 4;11(1):3044
pubmed: 33542262
Emerg Infect Dis. 2020 Oct;26(10):2497-2499
pubmed: 32497001
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Clin Infect Dis. 2020 Nov 03;:
pubmed: 33141180
Clin Infect Dis. 2021 Jul 1;73(1):148-150
pubmed: 32761228
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Clin Infect Dis. 2021 Oct 5;73(7):1805-1813
pubmed: 33185244
J Glob Health. 2020 Jun;10(1):011101
pubmed: 32612817
Clin Infect Dis. 2021 Jun 1;72(11):e761-e767
pubmed: 32986120
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Br J Anaesth. 2020 Sep;125(3):e330-e332
pubmed: 32534738
Clin Infect Dis. 2021 Jun 15;72(12):e970-e977
pubmed: 33180914
J Clin Microbiol. 2021 Apr 20;59(5):
pubmed: 33563599
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Clin Infect Dis. 2021 Jun 15;72(12):e1146-e1153
pubmed: 33283240
J Pediatr. 2020 Dec;227:45-52.e5
pubmed: 32827525
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447